Project/Area Number |
10670207
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Experimental pathology
|
Research Institution | Okayama University |
Principal Investigator |
KONDO Eisaku Medical School, Okayama University, Assistant, 医学部, 助手 (30252951)
|
Co-Investigator(Kenkyū-buntansha) |
MATSUSHITA Masayuki Medical School, Okayama University, Assistant, 医学部, 助手 (30273965)
MORIWAKI Akiyoshi Medical School, Okayama University, Lecturer, 医学部, 講師 (10144742)
MATSUI Hideki Medical School, Okayama University, Professor, 医学部, 教授 (30157234)
|
Project Period (FY) |
1998 – 1999
|
Project Status |
Completed (Fiscal Year 1999)
|
Budget Amount *help |
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 1999: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1998: ¥2,600,000 (Direct Cost: ¥2,600,000)
|
Keywords | calcineurin / Bcl-2 / apoptosis / dephosphorylation / リン酸化制御 / 神経細胞死 / Bリンパ球 / Bc1-2 |
Research Abstract |
The serine/threonine protein phosphatase 2B, calcineurin, was revealed to be bound to anti-apoptotic protein, Bcl-2. Calcineurin specifically dephosphorylated Bcl-2 through its direct association. Dephosphorylated Bcl-2 by active calcineurin functioned as an apoptosis-suppressor, whereas phosphorylated Bcl-2 by inactivation of calcineurin (by overexpression of dominant negative type of calcineurin) lost the anti-apoptotic function. Phosphorylation assay revealed that target regions for dephosphorylation by calcineurin were located both a BH4 domain and Loop within Bcl-2, which suggested Ser24 on BH4 and Ser70 on loop seemed to be the candidates, respectively. Cells expressing mutative Bcl-2 substituted those Serines by Alanine(A) or Aspartate(D) showed consistent biological behaviors to genetic analyses of altered function of Bcl-2 by phorylation regulation. It was clarified, as a mechanism of apoptosis regulation by Bcl-2, that the phosphorylated status of Bcl-2 affected its affinity to death-induced, Bax. Namely, dephosphorylated Bcl-2 efficiently heterodimerized to Bax, whereas phosphorylated Bcl-2 lost its association to Bax, thus excess amount of Bax accumulated at mitochondria caused apoptosis by facilitating a relase of cytochrome C. In vivo study using human leukemia/lymphoma cell lines revealed that cells carrying t(14 ; 18) chromosomal translocation predominantly overexpressed dephosphorylated form of endogenous Bcl-2. It also revealed that apoptotic leukemia cells treated by anti-cancer drug showed mobility shift of endogenous Bcl-2 from dephosphorylated form to phosphorylated form.
|